Search

Search Constraints

You searched for: Author/Creator Kuo, Hsing‐Tao

Search Results

1. A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C. Issue 11 (10th October 2022)

2. Benefits of stronger Neo‐Minophagen C in acute hepatitis after transarterial chemoembolization therapy for hepatomas. Issue 1 (28th February 2022)

3. Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy. Issue 2 (6th October 2020)

4. Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan. (12th March 2021)

5. Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort). Issue 10 (21st May 2021)

6. High pre‐operative serum aminotransferase levels predict local recurrence after curative resection of hepatocellular carcinoma. Issue 1 (23rd April 2014)

9. Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan. Issue 8 (30th March 2021)